Skip to main content
. Author manuscript; available in PMC: 2018 Jun 13.
Published in final edited form as: Kidney Int. 2018 Apr 12;93(6):1281–1292. doi: 10.1016/j.kint.2018.02.006

Figure 1. Schematic presentation of chronic kidney disease (CKD) categories and conference focus.

Figure 1

Per definition, CKD G5 includes patients with kidney failure with and without kidney replacement therapy (KRT). The conference focus (dashed line) was on patients within glomerular filtration rate (GFR) categories G4 and G5, excluding individuals already on KRT, but including KRT as an important end point. D = patients on dialysis therapy, T = patients with a kidney transplant. Colors reflect different risk categories for adverse outcomes as compared with individuals without CKD: green = no increase in risk; yellow = slightly elevated risk; orange = moderately elevated risk; and red = severely elevated risk. Adapted with permission from Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1–150.1